Researchers in Spain Wednesday announced the development of a prototype vaccine against HIV, the virus that causes aids.
At a news conference in Madrid, researchers said after showing a high level of efficiency in mice and monkeys, testing began in humans a year ago. Of the subjects receiving the vaccine, 95-percent developed bodily defenses and managed to stimulate both the production of cells and antibodies. The next round of tests will be on volunteers already infected with HIV to see if it can be used to treat aids as well as prevent it.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.